In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 1, 2012, Pages 65.e1-65.e10

  Anderson, Brenna L ^a   Ghosh, Mimi ^b,c   Raker, Christina ^a   Fahey, John ^b   Song, Yan ^b   Rouse, Dwight J ^a   Wira, Charles R ^b   Cu Uvin, Susan ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

cervicovaginal lavage; cervicovaginal secretions; HIV; pregnancy

Indexed keywords

ELAFIN; EOTAXIN; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MENSTRUATION; NORMAL HUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RACE; SECOND TRIMESTER PREGNANCY; UTERINE CERVIX CYTOLOGY; VIRUS INFECTIVITY; VIRUS STRAIN;

EID: 84862676801     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.04.029     Document Type: Article

References (29)

1. AIDS Epidemic Update. 2008. Available at http://data.unaids.org/pub/ GlobalReport/2008/jc1510-2008-global-report-pp29-62-en.pdf. Accessed Feb. 1, 2012.
2. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991;266:1664-7.
3. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. BMJ 1992;304:809-13.
4. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005;366:1182-8.
5. Morrison CS, Wang J, Van Der Pol B, Padian N, Salata RA, Richardson BA. Pregnancy and the risk of HIV-1 acquisition amongwomenin Uganda and Zimbabwe. AIDS 2007;21:1027-34.
6. Patterson KB, Leone PA, Fiscus SA, et al. Frequent detection of acute HIV infection in pregnant women. AIDS 2007;21:2303-8.
7. Reid SE, Dai JY, Wang J, et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. JAIDS 2010;53:606-13.
8. Stock SJ, Duthie L, Tremaine T, Calder AA, Kelly RW, Riley SC. Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reprod Sci 2009;16:1125-34.
9. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000;183:1243-8.
10. Tromp G, Kuivaniemi H, Romero R, et al. Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes. Am J Obstet Gynecol 2004;191:1331-8.
11. Polonis VR, Brown BK, Borges AR, et al. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 2008;375:315-20.
12. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR. CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 2009;62:60-71.
13. Keller MJ, Mesquita PMM, Torres NM, et al. Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. PLoS ONE [Electronic Resource] 2010;5:e8781.
14. Mselle TF, Howell AL, Ghosh M, Wira CR, Sentman CL. Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus Type 1 infection by secretion of CXCL12. J Virol 2009;83:11188-95.
15. Ghosh M, Fahey JV, Shen Z, et al. Anti-HIV Activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS ONE 2010;5:e11366.
16. Wira CR, Fahey JV, Ghosh M, et al. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 2010;63:544-65.
17. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74.
18. van der Straten A, van Damme L, Haberer JE, Bangsberg DR. How well does PREP work? Unraveling the divergent results of PrEP trials for HIV prevention. AIDS 2012;26:F13-9.
19. Simhan HN, Caritis SN, Krohn MA, Martinez de Tejada B, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003;189:560-7.
20. Wira CR, Fahey JV. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008;22:1909-17.
21. Moreau T, Baranger K, Dadé S, Dallet-Choisy S, Guyot N, Zani M-L. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 2008;90:284-95.
22. Cole AM. Innate host defense of human vaginal and cervical mucosae. Curr Topics Microbiol Immunol 2006;306:199-230.
23. Cole AM, Cole AL. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol 2008;59:27-34.
24. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR. CCL20/MIP3α is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 2009;62:60-71.
25. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2009;129:207-19.
26. Keller MJ, Guzman E, Hazrati E, et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007;21:467-76.
27. Beigi RH, Yudin MH, Cosentino L, Meyn LA, Hillier SL. Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis 2007;196:1355-60.
28. Donders GG, Vereecken A, Bosmans E, Spitz B. Vaginal cytokines in normal pregnancy. Am J Obstet Gynecol 2003;189:1433-8.
29. Mor G, Abrahams VM. The immunology of pregnancy. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, eds. Creasy & Resnik's maternal-fetal medicine. Philadelphia, PA: Saunders Elsevier; 2009:87-99.